Stock & Company Details
Immunovant Inc $IMVT
Price:
46,691,331
205M
$7.9B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
IMVT technical indicators
Latest Immunovant Inc (IMVT) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
67.83 3.8%
MACD:
2.09 2.3%
SMA 50:
$31.78 0.6%
SMA 200:
$25.55 0.4%
EMA 20:
$35.69 0.7%
Bollinger Bands:
40.86 / 28.97
Stochastic:
89.58 3.2%
ADX 14:
37.64 1.9%
ATR 14:
1.54 2.0%
CCI 20:
82.35 18.2%
OBV:
78.15M 1.0%
ROC 12:
13.44% 21.8%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
mmunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.
Finance Bot
Ask your questions
Start by typing a question below.
